San Diego, CA, United States of America

John D Fikes

USPTO Granted Patents = 9 

 

 

Average Co-Inventor Count = 4.5

ph-index = 8

Forward Citations = 222(Granted Patents)


Location History:

  • Utrecht, NL (2018)
  • San Diego, CA (US) (1998 - 2020)

Company Filing History:


Years Active: 1998-2020

Loading Chart...
Loading Chart...
Loading Chart...
9 patents (USPTO):Explore Patents

Title: The Innovations of John D. Fikes: Pioneering Cancer Immunotherapy

Introduction

John D. Fikes, an accomplished inventor based in San Diego, CA, has made significant strides in the field of cancer immunotherapy. With a total of 9 patents to his name, Fikes is recognized for his innovative contributions that aim to enhance cancer treatment and prevention.

Latest Patents

Among Fikes' most notable patents are those related to HLA-DR binding peptides and their uses. These peptides are derived from ovarian and breast cancer-associated antigens, including Human Epidermal Growth Factor Receptor 2 (HER-2/neu), Carcinoembryonic Antigen (CEA), Insulin Growth Factor Binding Protein 2 (IGFBP-2), and Cyclin D1. The immunogenic peptides developed through his research have potential applications in cancer vaccines, offering hope for improved therapeutic options. Another significant patent includes the development of HLA-A2 tumor-associated antigen peptides and compositions, featuring a peptide or composition comprising at least one HLA-A2 epitope or analog from targets such as CEA, HER2/neu, MAGE2, MAGE3, or p53. These innovations have the potential to significantly impact cancer treatment methodologies.

Career Highlights

Throughout his career, John D. Fikes has been associated with prominent companies in the biotechnology sector, including Epimmune Inc. and Ose Pharma International S.A. His work in these organizations has contributed to the advancement of cancer immunotherapy research and development.

Collaborations

Fikes has collaborated with esteemed professionals in the field, such as Alessandro D. Sette and Robert W. Chesnut. Their collective expertise has played a crucial role in the development of groundbreaking technologies that target cancer antigens, showcasing the importance of teamwork in innovation.

Conclusion

John D. Fikes stands as a notable figure in the realm of cancer research and immunotherapy. With his innovative patents and collaborative efforts, he continues to pave the way for future advancements in treating and preventing cancer. His work not only contributes to the scientific community but also offers hope to countless patients affected by this challenging disease.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…